GlassScriptPhysician profile
Caroline Breit
NPI 1083292031
$360.34
in general payments reported to CMS, 2019-2025
10 companies · $99.09 in 2025
The $99.09 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.22 · 2023: $99.97 · 2024: $147 · 2025: $99.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $58.93 | 2023 | |
| Merck Sharp & Dohme LLC | $53.11 | 2024-2025 | Zerbaxa |
| Mimedx Group, INC. | $49.99 | 2024 | |
| Teleflex LLC | $43.14 | 2025 | Quikclot, Deknatel |
| Csl Behring | $41.04 | 2023 | Kcentra |
| Polynovo North America LLC | $28.10 | 2024 | Novosorb Btm |
| Medtronic, INC. | $27.29 | 2025 | Transorb |
| Alcresta Therapeutics, INC. | $23.72 | 2024 | Relizorb |
| Astrazeneca Pharmaceuticals LP | $20.80 | 2024 | |
| Kci USA, INC. | $14.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Breit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.